#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia Alzheimer's type Ichthyosis Ewing's sarcoma recurrent Candida infection Metastases to central nervous system Glioma Medullary thyroid cancer Extranodal marginal zone B-cell lymphoma (MALT type) Piriformis syndrome Demyelination Angiosarcoma metastatic Sexually transmitted disease Neuroendocrine carcinoma metastatic Pelizaeus-Merzbacher disease Hypoparathyroidism More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Life with Disease Mucopolysaccharidosis III Medulloblastoma recurrent – Basic Information Leiomyosarcoma metastatic – Trials in Disease Shprintzen-Goldberg syndrome Prader-Willi syndrome – Trials in Disease Primary biliary cholangitis – Basic Information Hereditary hypophosphataemic rickets – Basic Information Breast angiosarcoma metastatic – Trials in Disease Myelodysplastic syndrome with excess blasts – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tiotropium Bromide Tranexamic Acid 7-Ethyl-10-Hydroxycamptothecin Remestemcel Aldesleukin Seralutinib Tucatinib Sorafenib Iohexol Sildenafil Citrate Ilofotase Alfa Plerixafor Telisotuzumab Vedotin Omalizumab Paracetamol Dc Human Coagulation Factor Ii LUXDEGALUTAMIDE Fludarabine Corylus Avellana L. Istem-01 More therapies…

    Learn about Your Condition

    Affective disorder Aortic valve stenosis Papulopustular rosacea Liver transplant rejection Bladder cancer recurrent Bladder cancer stage II Bladder cancer Post procedural complication Bipolar disorder Alveolar proteinosis Bladder cancer stage III Bipolar I disorder Biotinidase deficiency Infertility male Type 2 diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer…

Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer

5s Rps Hrggx Sfudcd Cavvhb Dpbjbqvo Thumesu 8ktvaz Fzjqhc

Want to learn more about this study or check if you can participate? Contact us.

  • Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Topotecan Hydrochloride
    Austria Belgium Czechia Denmark France Germany +5

  • One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    France

  • Anti‑PD1 Therapy with pembrolizumab and cemiplimab in first‑line advanced non‑small cell lung cancer patients with high PD‑L1 expression

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Cemiplimab
    • Pembrolizumab
    France

  • Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    • Small cell lung cancer
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • BNT327
    • Atezolizumab
    • Carboplatin
    France Germany Italy The Netherlands Poland Romania +1

  • Study of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • LIGUFALIMAB
    • Ivonescimab
    • Pembrolizumab
    Belgium France Spain

  • Study of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    France

  • Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

    Recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    Bulgaria Czechia France Hungary Poland Spain

  • Comparing tarlatamab with standard chemotherapy in patients with pre-treated advanced pulmonary or gastroenteropancreatic neuroendocrine carcinomas

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour of the lung
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Dacarbazine
    • Irinotecan Hydrochloride Trihydrate
    • Atezolizumab
    France

  • Study of WSD0922-FU for Patients with Advanced Non-Small Cell Lung Cancer and C797S Mutation After Osimertinib Treatment

    Recruiting

    2 1 1
    France

  • Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • SIGVOTATUG VEDOTIN
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia Denmark France +9
1 2 3 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!